4.7 Editorial Material

Opioid Tapering Practices-Time for Reconsideration?

Related references

Note: Only part of the references are listed.
Article Substance Abuse

I felt like I had a scarlet letter: Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain

Allyn Benintendi et al.

Summary: Patients with chronic non-cancer pain undergoing opioid tapering experienced structural stigma, feeling overlooked in the opioid crisis, stigmatized by cultural norms, and further marginalized by institutional policies and programs. The tapering initiatives exacerbated social stigma and unintended consequences, highlighting the devalued status of chronic pain patients and undermining their confidence in medical systems.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Clinical Neurology

Opioid Policy and Chronic Pain Treatment Access Experiences: A Multi-Stakeholder Qualitative Analysis and Conceptual Model

Stephanie Slat et al.

Summary: The study identified six main barriers to treatment access for patients with chronic pain, including clinic reluctance to manage prescribed opioids, lack of time and reimbursement for quality opioid-related care, scarcity of multimodal care and coordination between providers, fear of liability and use of new guidelines, delayed prescription receipt due to prior authorization and pharmacy issues, and poor availability of effective non-opioid treatments. These issues converge to disrupt treatment access for patients with chronic pain, highlighting the need for policy interventions to address these access barriers.

JOURNAL OF PAIN RESEARCH (2021)

Article Medicine, General & Internal

Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids

Alicia Agnoli et al.

Summary: Among patients prescribed stable, long-term, higher-dose opioid therapy, tapering events were significantly associated with increased risk of overdose and mental health crisis. The study suggests that reducing opioid doses may lead to negative outcomes such as overdose and mental health crisis.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Health Care Sciences & Services

Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study

Hector R. Perez et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2020)

Review Health Care Sciences & Services

Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review

Katherine Mackey et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2020)

Editorial Material Medicine, General & Internal

No Shortcuts to Safer Opioid Prescribing

Deborah Dowell et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids

Pooja A. Lagisetty et al.

JAMA NETWORK OPEN (2019)

Article Health Care Sciences & Services

Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: A Delphi Study

Jessica S. Merlin et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2018)

Article Pharmacology & Pharmacy

Untitled

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)

Review Medicine, General & Internal

Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy A Systematic Review

Joseph W. Frank et al.

ANNALS OF INTERNAL MEDICINE (2017)

Review Medicine, General & Internal

CDC Guideline for Prescribing Opioids for Chronic Pain-United States, 2016

Deborah Dowell et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)